# Bloodworks – FDA Inspection, May 10, 2019

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/7ba6cb88-cf8d-4185-81aa-79ea72a3101b
Source feed: FDA_Inspections

> FDA inspection 1089146 of Bloodworks, May 10, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 630. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089146
- Company Name: Bloodworks
- Inspection Date: 2019-05-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1223133 - 2023-11-08
- FDA Inspection 1019353 - 2017-07-17
- FDA Inspection 884146 - 2014-06-23
- [FDA Inspection 796827 - 2012-08-20](https://www.keypedia.com/records/fda_inspections/bloodworks/d0e838b2-7875-4d20-9b76-c5ca4cb74adc)
- [FDA Inspection 718978 - 2011-04-05](https://www.keypedia.com/records/fda_inspections/bloodworks/ea4f415d-a126-40d9-a63b-6e5b557a25f4)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/peter-s-kessler/f3a9dea7-3a2d-4c86-9ec6-97791f9b6c21)

Company: https://www.keypedia.com/companies/bloodworks/f2ad1a4e-fc84-4177-9ed6-fd42a6088ea6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d